Table 2.
Clinical features
Study group | n | Age, yrs | BMI, kg/m2 | Gravidity | Parity |
---|---|---|---|---|---|
PCOS probands | n = 80 | 29 ± 7 | 33.3 ± 8.2† | 0.6 ± 1.0‡ | 0.3 ± 0.7†‡ |
PCOS sisters | n = 17 | 25 ± 7 | 33.6 ± 9.0† | 0.4 ± 0.7‡ | 0.2 ± 0.6‡ |
HA sisters | n = 19 | 26 ± 7 | 28.8 ± 6.1 | 1.3 ± 1.4 | 0.9 ± 1.1 |
UA sisters | n = 43 | 31 ± 10 | 26.0 ± 6.8‡ | 1.3 ± 1.4 | 1.1 ± 1.3 |
Control subjects | n = 70 | 30 ± 7 | 31.7 ± 8.9 | 1.7 ± 1.9 | 1.2 ± 1.4 |
ANOVA P-value | 0.04 | <0.0001 | <0.0001 | <0.0001 |
Values are given as mean ±SD. P values were derived from ANOVA with Scheffe’s post hoc test. Significant values are noted:
, vs. UA sisters;
, vs. control subjects.